Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

BACKGROUND: Nemolizumab is deemed as a promising drug for atopic dermatitis (AD) patients with pruritus. OBJECTIVE: This study aimed to evaluate the efficacy of nemolizumab in treating patients with AD and the association between the dosage or regimen of nemolizumab with the improvement in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Junqin, Hu, Fengxia, Dan, Maoli, Sang, Yingbing, Abulikemu, Kailibinuer, Wang, Qian, Hong, Yongzhen, Kang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086972/
https://www.ncbi.nlm.nih.gov/pubmed/35558086
http://dx.doi.org/10.3389/fimmu.2022.825312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086972/
https://www.ncbi.nlm.nih.gov/pubmed/35558086
http://dx.doi.org/10.3389/fimmu.2022.825312

Ejemplares similares